Onofrio Laselva

1.6k total citations
49 papers, 1.0k citations indexed

About

Onofrio Laselva is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Onofrio Laselva has authored 49 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in Onofrio Laselva's work include Cystic Fibrosis Research Advances (40 papers), Neonatal Respiratory Health Research (26 papers) and Tracheal and airway disorders (11 papers). Onofrio Laselva is often cited by papers focused on Cystic Fibrosis Research Advances (40 papers), Neonatal Respiratory Health Research (26 papers) and Tracheal and airway disorders (11 papers). Onofrio Laselva collaborates with scholars based in Italy, Canada and United States. Onofrio Laselva's co-authors include Christine E. Bear, Theo J. Moraes, Tanja Gonska, Hong Ouyang, Claire Bartlett, Valeria Casavola, T. Gunawardena, Steven V. Molinski, Massimo Conese and Paul D. W. Eckford and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Advanced Functional Materials.

In The Last Decade

Onofrio Laselva

46 papers receiving 1.0k citations

Peers

Countries citing papers authored by Onofrio Laselva

Since Specialization

Citations

This map shows the geographic impact of Onofrio Laselva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Onofrio Laselva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Onofrio Laselva more than expected).

Fields of papers citing papers by Onofrio Laselva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Onofrio Laselva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Onofrio Laselva. The network helps show where Onofrio Laselva may publish in the future.

Co-authorship network of co-authors of Onofrio Laselva

This figure shows the co-authorship network connecting the top 25 collaborators of Onofrio Laselva. A scholar is included among the top collaborators of Onofrio Laselva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Onofrio Laselva. Onofrio Laselva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Target Identification with Live-Cell Photoaffinity Labeling and Mechanism of Action Elucidation of ARN23765, a Highly Potent CFTR Corrector 2025 ·Journal of Medicinal Chemistry ·Elisa Romeo, Francesco Saccoliti, (unknown), (unknown), (unknown), (unknown), Nicoletta Pedemonte, Federico Falchi, Onofrio Laselva, Tiziano Bandiera, Fabio Bertozzi	0
2	IL-17 family members exert an autocrine pro-inflammatory loop in CF respiratory epithelial cells ex vivo 2025 ·Cellular Immunology ·(unknown), Enza Montemitro, Fabiana Ciciriello, Michele Altieri, (unknown), Giulia Breveglieri, Monica Borgatti, Giulio Cabrini, Onofrio Laselva	0
3	Testing organ-specific responses to therapies in tissues differentiated from Cystic Fibrosis patient derived iPSCs 2025 ·Stem Cell Research ·(unknown), Sunny Xia, Onofrio Laselva, (unknown), Christine E. Bear	2
4	Deleterious effect of Pseudomonas aeruginosa on F508del-CFTR rescued by elexacaftor/tezacaftor/ivacaftor is clinical strain-dependent in patient-derived nasal cells 2024 ·ERJ Open Research ·(unknown), Enza Montemitro, (unknown), Valeria Capurro, Emanuela Pesce, Fabiana Ciciriello, Gianfranco La Bella, (unknown), (unknown), Fabio Arena, T. Gunawardena, Lorenzo Guerra, Nicoletta Pedemonte, Nazzareno Capitanio, Cláudia Piccoli, Onofrio Laselva	0
5	IGFBP-6 Network in Chronic Inflammatory Airway Diseases and Lung Tumor Progression 2023 ·International Journal of Molecular Sciences ·Santina Venuto, Anna Rita Daniela Coda, Ruperto González‐Pérez, Onofrio Laselva, Doron Tolomeo, Clelia Tiziana Storlazzi, Arcangelo Liso, Massimo Conese	4
6	Olive Leaf Extract (OLE) as a Novel Antioxidant That Ameliorates the Inflammatory Response in Cystic Fibrosis 2023 ·Cells ·(unknown), Graziana Difonzo, Francesco Caponio, Grazia Tamma, Onofrio Laselva	12
7	The Oncogenic Theory of Preeclampsia: Is Amniotic Mesenchymal Stem Cells-Derived PLAC1 Involved? 2023 ·International Journal of Molecular Sciences ·Massimo Conese, (unknown), Onofrio Laselva, Sante Di Gioia, Luigi Nappi, Luigia Trabace, Maria Matteo	3
8	Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells 2022 ·Frontiers in Molecular Biosciences ·Onofrio Laselva, (unknown), (unknown), Sante Di Gioia, Arcangelo Liso, Massimo Conese	9
9	Characterization of anti-proliferative and anti-oxidant effects of nano-sized vesicles from Brassica oleracea L. (Broccoli) 2022 ·Scientific Reports ·(unknown), Vincenzo De Leo, Rosanna Tamborra, Onofrio Laselva, Chiara Ingrosso, (unknown), Lucia Catucci, Ilario Losito, Francesco Sollitto, Domenico Loizzi, Massimo Conese, Sante Di Gioia	14
10	A protocol for identifying the binding sites of small molecules on the cystic fibrosis transmembrane conductance regulator (CFTR) protein 2022 ·STAR Protocols ·Onofrio Laselva, Evgeniy V. Petrotchenko, (unknown), Zafar Qureshi, Christoph H. Borchers, Robert N. Young, Christine E. Bear	2
11	Identification of binding sites for ivacaftor on the cystic fibrosis transmembrane conductance regulator 2021 ·iScience ·Onofrio Laselva, Zafar Qureshi, (unknown), Evgeniy V. Petrotchenko, Mohabir Ramjeesingh, (unknown), Ling‐Jun Huan, Christoph H. Borchers, Régis Pomès, Robert N. Young, Christine E. Bear	36
12	Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation 2021 ·Journal of Cystic Fibrosis ·Yifat S. Oren, (unknown), E. Ozeri-Galai, (unknown), (unknown), (unknown), (unknown), (unknown), Onofrio Laselva, Malena Cohen‐Cymberknoh, Eitan Kerem, Christine E. Bear, Batsheva Kerem	22
13	A new platform for high-throughput therapy testing on iPSC-derived lung progenitor cells from cystic fibrosis patients 2021 ·Stem Cell Reports ·(unknown), Leigh Wellhauser, Onofrio Laselva, (unknown), Zoltán Bozóky, T. Gunawardena, (unknown), Sunny Xia, Michelle Di Paola, Paul D. W. Eckford, Félix Ratjen, Theo J. Moraes, John Parkinson, Amy P. Wong, Christine E. Bear	21
14	The era of CFTR modulators: improvements made and remaining challenges 2020 ·Breathe ·(unknown), Onofrio Laselva, Julie Avolio, Raffaella Nenna	24
15	Emerging preclinical modulators developed for F508del-CFTR have the potential to be effective for ORKAMBI resistant processing mutants 2020 ·Journal of Cystic Fibrosis ·Onofrio Laselva, Claire Bartlett, (unknown), Hong Ouyang, T. Gunawardena, Tanja Gonska, Theo J. Moraes, Christine E. Bear	32
16	A helper-dependent adenoviral vector rescues CFTR to wild-type functional levels in cystic fibrosis epithelial cells harbouring class I mutations 2020 ·European Respiratory Journal ·Huibi Cao, Hong Ouyang, Onofrio Laselva, Claire Bartlett, (unknown), (unknown), T. Gunawardena, Julie Avolio, Christine E. Bear, Tanja Gonska, Jim Hu, Theo J. Moraes	23
17	Rescue of multiple class II CFTR mutations by elexacaftor+tezacaftor+ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator 2020 ·European Respiratory Journal ·Onofrio Laselva, Claire Bartlett, T. Gunawardena, Hong Ouyang, Paul D. W. Eckford, Theo J. Moraes, Christine E. Bear, Tanja Gonska	109
18	ORKAMBI-Mediated Rescue of Mucociliary Clearance in Cystic Fibrosis Primary Respiratory Cultures Is Enhanced by Arginine Uptake, Arginase Inhibition, and Promotion of Nitric Oxide Signaling to the Cystic Fibrosis Transmembrane Conductance Regulator Channel 2019 ·Molecular Pharmacology ·(unknown), (unknown), Saumel Ahmadi, (unknown), Onofrio Laselva, Sunny Xia, Claire Bartlett, Wan Ip, Leigh Wellhauser, Hong Ouyang, Tanja Gonska, Theo J. Moraes, Christine E. Bear	39
19	Functional rescue of c.3846G>A (W1282X) in patient-derived nasal cultures achieved by inhibition of nonsense mediated decay and protein modulators with complementary mechanisms of action 2019 ·Journal of Cystic Fibrosis ·Onofrio Laselva, Paul D. W. Eckford, Claire Bartlett, Hong Ouyang, (unknown), Tanja Gonska, Theo J. Moraes, Christine E. Bear	51
20	The investigational Cystic Fibrosis drug Trimethylangelicin directly modulates CFTR by stabilizing the first membrane-spanning domain 2016 ·Biochemical Pharmacology ·Onofrio Laselva, Steven V. Molinski, Valeria Casavola, Christine E. Bear	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact